Literature DB >> 2812870

Aeromonas septicemia: relationship of species and clinical features.

M Dryden1, R Munro.   

Abstract

Thirteen patients with Aeromonas species septicemia were seen at Westmead Hospital between 1983 and 1987. In 10 patients (77%) septicemia was caused by A. sobria, and in 3 (23%) by A. hydrophila, A. caviae was not isolated. Chronic underlying illness was present in 10 patients (77%), hematological malignancy being the most common (46%). The average age of the patients was 65.8 years. Seven patients (54%) presented with clinical sepsis, diarrhea and abdominal pain. The biliary tract, lung and soft tissue were other primary sites of infection. Nosocomial infection occurred in 5 patients (38%). Cross-infection was not seen. Contact with fresh water or fish was observed in only 2 patients (15%). The majority of cases occurred in the warmer months of the year. The overall mortality was 46%. All isolates of Aeromonas species were resistant to ampicillin 8 mg/L. Ten isolates were resistant to tobramycin 1 mg/L, and 3 to tobramycin 4 mg/L. In contrast, 3 isolates were resistant to gentamicin 1 mg/L, and none to 4 mg/L. The isolates showed a varied pattern of resistance to other antibiotics tested, but all were susceptible to piperacillin 64 mg/L, imipenem 4 mg/L, ciprofloxacin 1 mg/L, and amikacin 16 mg/L.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812870     DOI: 10.3109/00313028909059546

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  11 in total

1.  Aeromonas hydrophila: myofascial necrosis and sepsis.

Authors:  R B Vukmir
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 2.  Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas.

Authors:  J M Janda
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

Review 3.  Alzheimer disease.

Authors:  David S Knopman; Helene Amieva; Ronald C Petersen; Gäel Chételat; David M Holtzman; Bradley T Hyman; Ralph A Nixon; David T Jones
Journal:  Nat Rev Dis Primers       Date:  2021-05-13       Impact factor: 52.329

4.  Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.

Authors:  W C Ko; K W Yu; C Y Liu; C T Huang; H S Leu; Y C Chuang
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.

Authors:  J M Koehler; L R Ashdown
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.

Authors:  Wen-Chien Ko; Shyh-Ren Chiang; Hsin-Chun Lee; Hung-Jen Tang; Yin-Yi Wang; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Different clinical characteristics among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae monomicrobial bacteremia.

Authors:  Han-Chuan Chuang; Yu-Huai Ho; Chorng-Jang Lay; Lih-Shinn Wang; Yeong-Shu Tsai; Chen-Chi Tsai
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

8.  Aeromonas hydrophila Sepsis Associated with Consumption of Raw Oysters.

Authors:  Ivan Nikiforov; John Goldman; Pramil Cheriyath; Anix Vyas; Vinod Nookala
Journal:  Case Rep Infect Dis       Date:  2014-11-19

9.  Septicemia due to Aeromonas hydrophila in a pregnant woman: a case report and review of the literature.

Authors:  R F Damián; R V Zesati; L S Fernáindez; J L García
Journal:  Infect Dis Obstet Gynecol       Date:  1995

Review 10.  Edwardsiella tarda bacteremia. A rare but fatal water- and foodborne infection: Review of the literature and clinical cases from a single centre.

Authors:  Yuji Hirai; Sayaka Asahata-Tago; Yusuke Ainoda; Takahiro Fujita; Ken Kikuchi
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.